Administration of recombinant human thrombopoietin is associated with alleviated thrombocytopenia in adult intensive care unit patients with pneumonia: A single-center retrospective study

• Main Authors: Bailiang Chen (Author), Jiabin Xuan (Author), Feng Wu (Author), Nengxian Shi (Author), Jianwei Dai (Author), Shumin Cai (Author), Shengli An (Author), Qiaobing Huang (Author), Xiaoling Huang (Author), Zhongqing Chen (Author), Zhenhua Zeng (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Recombinant human thrombopoietin (rhTPO) is reported to stimulate platelet production and increase peripheral platelet counts; it is primarily used to manage chemotherapy-induced thrombocytopenia and idiopathic thrombocytopenic purpura. However, the effect of rhTPO in patients with pneum...